Tag: Medical Prices

Improper patents lead to substantially higher drug costs

The problem of wrongly granted patents leads to higher prices for patients, small and large employers, Medicare, and Medicaid – not to mention billions of dollars of “pure economic waste,” according to a new report from the Center for Economic and Policy Research. Continue reading

Posted in: Cost Alert

New Data Brief on Networks Ensuring Affordable, Accessible Specialty Care

For patients managing complex health conditions, health plans’ networks include a broad range of specialty provider and hospital groups that have a proven track-record of delivering high-quality care, according to a new AHIP data brief. Continue reading

Posted in: AHIP Studies and Reports

Durham Op-Ed: “The Great Threat of Rising Health Care Costs”

Today’s Morning Consult features an op-ed by AHIP Interim CEO Dan Durham, in which he states now is the time to focus on ensuring health care accessibility, affordability, and quality. However, Durham highlights underlying challenges that all stakeholders need to confront in order to move the health system forward. Continue reading

Posted in: AHIP in the News, Cost Alert

What’s behind health insurance premiums?

With recent discussions surrounding insurance premiums, it’s important to acknowledge an important fact: Premiums track directly with the underlying cost of care. Continue reading

Posted in: Health Care Costs

Striking down weak patents protects patients

In some cases, explosive drug prices are the result of drugmakers’ patent schemes that financially distress consumers and limit their treatment options. That is why a recent proposal to exempt pharmaceutical companies from a key consumer protection would leave families across the country even more hostage to egregious pharmaceutical prices. Continue reading

Posted in: AHIP Letters, Cost Alert

New Data Brief on Hospital Consolidation and Premiums

The growing body of evidence that hospital consolidation and higher premiums go hand-in-hand has yet another entry. A new AHIP data brief finds that as hospital consolidation increases, so too do premiums. Continue reading

Posted in: AHIP Studies and Reports, Health Care Costs

Hill Briefing Examines the Truth About Premiums

Influential factors that go into premiums took center stage this afternoon at a Capitol Hill briefing hosted by centrist think tank Third Way. The panelists all emphasized the fact that proposed premiums vary greatly; and therefore, it’s crucial to consider the full picture when looking at changes in premiums. Continue reading

Posted in: Cost Alert, On The Hill

Studies, experts agree: Provider consolidation drives up the cost of care

Here’s where it’s important to understand that insurance premiums track the underlying cost of medical care, like the cost of doctor’s visits, hospital stays, and prescription medications. So as the costs of medical care increase, so do premiums. One explanation for increases in hospital prices is consolidation among hospitals and other providers. Continue reading

Posted in: Cost Alert

Nearly $1 trillion in the next 5 years

Global prescription drug sales will grow 4.8 percent a year until reaching $987 billion by 2020, according to a new report from EvaluatePharma. Other findings from the report upend the concept that that research and development costs are driving high prescription drug prices. Continue reading

Posted in: Health Care Costs, Uncategorized

AHIP Briefing: Focus on the Price

Several stakeholders gathered in Washington, D.C., this morning for a panel discussion titled “Cost of Innovation: How the Future Drug Pipeline Will Impact Patient Access, Affordability.” Continue reading

Posted in: Health Care Costs